Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy

Japanese Journal of Ophthalmology

Volumn 46, Issue 4, 2002, Pages 406-412

  Matsumoto, Yukihiro ^a   Takahashi, Masaaki ^b   Ogata, Masafumi ^c  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Diabetic retinopathy; Glycoxidation; Pentosidine; Transforming growth factor 2; Vascular endothelial growth factor

Indexed keywords

HYDROGEN PEROXIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTOSIDINE; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OXIDATION; PRIORITY JOURNAL; VITRECTOMY; VITREOUS BODY;

ARGININE; CHEMOKINE CCL2; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOKINES; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYDROGEN PEROXIDE; LYMPHOKINES; LYSINE; MALE; MIDDLE AGED; OXIDATION-REDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITRECTOMY; VITREOUS BODY;

EID: 0036661750     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(02)00508-7     Document Type: Article

References (22)

1. Brownlee M. Advanced protein glycosylation in diabetes and aging. Ann Rev Med. 46:1995;223-224.
2. Monnier V.M., Glomb M., Elgawish A., Sell D.R. The mechanism of collagen cross-linking in diabetes. A puzzle nearing resolution. Diabetes. 45:1996;S67-S72.
3. Sell D.R., Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem. 264:1989;21597-21602.
4. Takahashi M., Kushida K., Kawana K.et al. Quantification of cross-link pentosidine in serum from normal and uremic subjects. Clin Chem. 39:1993;2162-2165.
5. Hashimoto H. Glycemic control goals by stage of diabetic retinopathy - from the viewpoint of ophthalmology. Nihon Ganka Kiyo (Folia Ophthalmol Jpn). 49:1998;981-988.
6. 2, VEGF, and pentosidine in the human vitreous with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 40:1999;S40.
7. Ahmed M.U., Thorpe S.R., Baynes J.W. Identification of N epsilon-carboxymethyllysine as a degradation product of fructose lysine in glycated protein. J Biol Chem. 261:1986;4889-4894.
8. Ishibashi T. Cell biology of intraocular vascular diseases. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc). 103:1999;923-947.
9. Hayase F., Nagaraj R.H., Miyata S., Njoroge F.G., Monnier V.M. Aging of protein. immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo J Biol Chem. 264:1989;3758-3764.
10. Hirata C., Nakano K., Nakamura N.et al. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells. Biochem Biophys Res Commun. 236:1997;712-715.
11. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
12. Litchfield J.E., Thorpe S.R., Baynes J.W. Oxygen not required for the browning and crosslinking of protein by pentose. relevance to Maillard reactions in vivo Int J Biochem Cell Biol. 31:1999;1297-1305.
13. Elgawish A., Glomb M., Freidlander M., Monnier V.M. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem. 271:1996;12964-12971.
14. Yamashita T. Functions of the transforming growth factor-beta superfamily in eyes. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc). 101:1997;927-947.
15. Clauss M., Gerlach M., Gerlach H.et al. Vascular permeability factor. a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration J Exp Med. 172:1990;1535-1545.
16. Limb G.A., Hickman-Casey J., Hollifield R.D., Chignell A.H. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 40:1999;2453-2457.
17. Lin J. Pathophysiology of cataract. copper ion and peroxidation in diabetes Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc). 100:1996;672-679.
18. Amin R.H., Frank R.N., Kennedy A.et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 38:1997;36-47.
19. Makita Z., Radoff S., Rayfield E.J.et al. Advanced glycosylation end-products in patients with diabetic nephropathy. N Engl J Med. 325:1991;836-842.
20. Odetti P., Fogarty J., Sell D.R., Monnier V.M. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes. 41:1992;153-159.
21. Lu M., Kuroki M., Amano S.et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest. 101:1998;1219-1224.
22. Kuroki M., Voest E.E., Amano S.et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest. 98:1996;1667-1675.